Steven LaRosa
Corporate Officer/Principal at AETHLON MEDICAL, INC.
Net worth: - $ as of 2024-04-29
Profile
Steven P.
LaRosa is currently the Chief Medical Officer at Aethlon Medical, Inc. and a Member at Beth Israel Lahey Health, Inc. He previously worked as the Medical Director-Antimicrobial Stewardship Program at Northeast Hospital Corp.
and as the Vice President-Clinical Development at Entasis Therapeutics, Inc. for a brief period in 2020.
LaRosa completed his undergraduate degree at Boston College and his doctorate at Boston University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AETHLON MEDICAL, INC.
-.--% | 2023-06-29 | 0 ( -.--% ) | - $ | 2024-04-29 |
Steven LaRosa active positions
| Companies | Position | Start |
|---|---|---|
| AETHLON MEDICAL, INC. | Corporate Officer/Principal | 2021-01-05 |
Beth Israel Lahey Health, Inc.
 Beth Israel Lahey Health, Inc. Medical/Nursing ServicesHealth Services Beth Israel Lahey Health, Inc. is a non-profir organization provides healthcare services. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Former positions of Steven LaRosa
| Companies | Position | End |
|---|---|---|
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 2020-11-30 |
| Northeast Hospital Corp. | Corporate Officer/Principal | - |
Training of Steven LaRosa
| Boston College | Undergraduate Degree |
| Boston University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AETHLON MEDICAL, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Northeast Hospital Corp. | |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Health Technology |
Beth Israel Lahey Health, Inc.
Beth Israel Lahey Health, Inc. Medical/Nursing ServicesHealth Services Beth Israel Lahey Health, Inc. is a non-profir organization provides healthcare services. The company is headquartered in Cambridge, MA. | Health Services |
- Stock Market
- Insiders
- Steven LaRosa
